Drug Type Small molecule drug |
Synonyms ADC-846 |
Target |
Mechanism USP19 inhibitors(ubiquitin specific peptidase 19 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cachexia | Preclinical | GB | 14 Apr 2023 |